Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
NewAmsterdam Pharma Company NV - Warrants (15/11/2027)
(NAMS+) Q3 2023
Earnings
NAMS+
Nov 29
Expected
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-1.8
-1.2
-0.6
-0
Details
Expected EPS
-0.4864
Actual EPS
0
Surprise EPS
0.49
Surprise Percent
+100%
Description
NewAmsterdam Pharma Company NV - Warrants (15/11/2027) (NAMS+) has reported earnings of 0 per share for Q3 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login